Deal Details

Sale to Experian plc

---

Summary

About

Medical Present Value, Inc. (“MPV” or the “Company”) recently completed its sale to Experian plc (“Experian”) (LSE:EXPN) for $185 million plus excess cash.

Founded in 1998, MPV is a leading provider of data and software to over 75,000 US physicians. Its products are used by healthcare providers to manage payments between patients, commercial payers (such as insurance companies) and government programs. In addition, MPV's products help to establish patients' eligibility for insurance or financial assistance, settle patient out-of-pocket expenses at the point of service and improve collections. MPV maintains a comprehensive database of healthcare claims data and serves over 300 major physician groups and academic medical institutions. The Company’s principal investors were Rho Ventures, CenterPoint Ventures, Star Ventures and Care Capital.

Experian is a leading global information services company, providing data and analytical tools to clients in more than 80 countries. The company helps businesses manage credit risk, prevent fraud, target marketing offers and automate decision making. Experian also helps individuals check their credit report and credit score, and protect against identity theft. Experian entered the U.S. healthcare payments sector in 2008 with the acquisition of SearchAmerica, as part of its strategy to expand its core data and analytics into new customer segments.

Baird’s Healthcare Services investment banking transaction experience, ongoing projects and frequent dialogue with key healthcare IT and services industry participants provide unique insights into industry dynamics, potential buyers’ areas of interest, M&A process strategy, and client market positioning. The sale of Medical Present Value represents Baird’s 14th HCIT/RCM transaction since 2007.

---

For additional information about this transaction, please contact: